Complications after CD19 CAR T-Cell therapy: a retrospective study from the EBMT Transplant Complications Working Party Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Olaf Penack
Bone marrow aplasia after CD19 CAR T-Cell therapy: a retrospective study from the EBMT Transplant Complications Working Party Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Olaf Penack
Retrospective study from the Transplant Complications Working Party (TCWP) in collaboration with the Infectious Diseases Working Party (IDWP) in the framework of the GoCART coalition Diseases Group Transplant Complications Working Party (TCWP) Infectious Diseases Working Party (IDWP) Principal investigator Christian Schultze-Florey
Role of HLA Evolutionary Divergence in Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Principal investigator
Association between HLA evolutionary divergence and leukemia relapse after allogeneic SCT from 10/10 HLA matched related/unrelated donor Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Principal investigator
Retrospective study on the incidence and outcome of Adenovirus infections in patients who undergo haploidentical SCT Diseases Group Infectious Diseases Working Party (IDWP) Principal investigator Maura Faraci
Outcome of allogeneic stem cell transplantation in patients with psychiatric disorders Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Zinaida Peric
Outcome of patients with Intermediate risk Acute Myelogenous Leukemia in first remission and no detectable residual disease (MRD negative) transplanted with a haploidentical donor versus autografted Group Acute Leukemia Working Party (ALWP) Type of transplant Principal investigator Norbert-Claude GORIN
Comparison of outcomes after unrelated double-unit cord blood and haploidentical peripheral blood stem cell transplantation in adults with acute myeloid leukemia, a study on behalf of Eurocord and ALWP-EBMT Group Acute Leukemia Working Party (ALWP) Principal investigator Annalisa Ruggeri
The role of measurable residual disease (MRD) at the time of allogeneic stem cell transplantation in patients with AML in CR transplanted from unrelated donors with Post transplant cyclophosphamide Group Acute Leukemia Working Party (ALWP) Principal investigator Arnon Nagler
PTCY MMUD vs Haplo in active disease for AML Group Acute Leukemia Working Party (ALWP) Principal investigator Frédéric Baron
Trends in non sibling donor in HSCT CR2 Diseases Group Acute Leukemia Working Party (ALWP) Principal investigator Mohamad Mohty